未找到相关数据
Valopicitabine (NM283), alone or with peginterferon, compared to peg interferon/ribavirin (pegIFN/RBV) retreatment in patients with HCV-1 infection and prior non-response to pegIFN/RBV: One-year results
被引：27
作者：
Afdhal, N.
O'Brien, C.
Godofsky, E.
Rodriguez-Torres, M.
Pappas, S. C.
Lawitz, E.
Pockros, P.
Sulkowski, M.
Jacobson, I.
Chao, G.
Knox, S.
Pietropaolo, K.
Brown, N. A.
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Univ Miami, Miami, FL 33152 USA
[3] Bach & Godofsky, Bradenton, FL USA
[4] Fdn Invest Diego, Santurce, PR USA
[5] St Lukes Episcopal Hosp, Houston, TX 77030 USA
[6] Alamo Med Res, San Antonio, TX USA
[7] Scripps Clin, La Jolla, CA USA
[8] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[9] Cornell Univ, Weill Med Coll, New York, NY USA
[10] Idenix Pharmaceut, Cambridge, MA USA
关键词：
D O I：
10.1016/S0168-8278(07)61604-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
6
引用
收藏
页码：S5 / S5
页数：1
相关论文